Multivariable linear regression was also performed to determine relationships between change in body weight and changes in study outcomes with semaglutide unadjusted and after adjusting (a priori) for age, sex, NYHA functional class, history of coronary artery disease, history of atrial fibrillation, baseline CRP and baseline NTproBNP levels
Zepbound , once-weekly injection for chronic weight management (FDA-approved 2023), clinical trials (SURMOUNT program) demonstrated up to 22.5% body weight loss, the highest of any approved anti-obesity medication
Avoid shaking the vial, as peptides are fragile proteins
Copper peptide GHK-Cu got its name because its comprised of the element copper and three linked amino acids or the tripeptide glycine, histidine, and lysine
What's Included
Administration: Subcutaneous injection Side Effects Mild water retention Temporary numbness in extremities Possible fatigue or flu-like symptoms 2